Feasibility and Efficacy of Prolonged Exposure for PTSD among Individuals with a Psychotic Spectrum Disorder by Grubaugh, Anouk L. et al.
fpsyg-08-00977 June 28, 2017 Time: 16:40 # 1
ORIGINAL RESEARCH















This article was submitted to
Clinical and Health Psychology,
a section of the journal
Frontiers in Psychology
Received: 02 November 2016
Accepted: 28 May 2017
Published: 28 June 2017
Citation:
Grubaugh AL, Veronee K, Ellis C,
Brown W and Knapp RG (2017)
Feasibility and Efficacy of Prolonged
Exposure for PTSD among Individuals
with a Psychotic Spectrum Disorder.
Front. Psychol. 8:977.
doi: 10.3389/fpsyg.2017.00977
Feasibility and Efficacy of Prolonged
Exposure for PTSD among
Individuals with a Psychotic
Spectrum Disorder
Anouk L. Grubaugh1,2*, Kimberly Veronee1,2, Charles Ellis3, Wilson Brown1,2 and
Rebecca G. Knapp4
1 Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC, United States, 2 Department of Psychiatry and
Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States, 3 Department of Communication
Sciences and Disorders, East Carolina University, Greenville, NC, United States, 4 Department of Public Health Sciences,
Medical University of South Carolina, Charleston, SC, United States
Objective: Few empirical studies have examined the feasibility of trauma-focused
treatment among individuals with schizophrenia. This lack of research is important
given the substantial overlap of trauma exposure and subsequent PTSD with psychotic
spectrum disorders, and the potential for PTSD to complicate the course and prognosis
of schizophrenia and other variants of severe mental illness.
Method: As part of a larger study, 14 veterans with a psychotic spectrum disorder
were enrolled to receive prolonged exposure (PE) for PTSD within a single arm open trial
study design. Patient reactions and responses to PE were examined using feasibility
indices such as attrition, survey reactions, and treatment expectancy; pre and post-
changes in PTSD severity and diagnostic status; and thematic interviews conducted
post-intervention.
Results: Quantitative and qualitative data indicate that implementation of PE is feasible,
subjectively well-tolerated, and may result in clinically significant reductions in PTSD
symptoms in patients with psychotic spectrum disorders.
Conclusion: Consistent with treatment outcome data in clinical populations with a
broader range of severe mental illnesses, the current results support the use of PTSD
exposure-based interventions, such as PE, for individuals with psychotic spectrum
disorders.
Keywords: severe mental illness (SMI), trauma, exposure therapy, psychotic disorder, schizophrenia
INTRODUCTION
It is well documented that individuals with severe and persistent forms of mental illness (SMI)
are at increased risk for the experience of a traumatic event and subsequent development of
post-traumatic stress disorder (PTSD; see Grubaugh et al., 2011 for review). Specifically, current
and lifetime prevalence rates of PTSD in this population range between 46 and 53% (Grubaugh
et al., 2011). Additionally, a comorbid diagnosis of PTSD among individuals with SMI is highly
correlated with decreased psychosocial functioning, worse quality of life, and substance use (e.g.,
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Mueser et al., 2004a,b; Ford and Fournier, 2007; Fan et al.,
2008; Grubaugh et al., 2011); as well as a range of other
prognostic indicators such as homelessness, disability ratings,
suicidal ideation (e.g., Sautter et al., 1999; Mueser et al., 2004b;
Strauss et al., 2006; Newman et al., 2010), and exacerbations
in the core symptoms of SMI diagnoses (e.g., Kilcommons and
Morrison, 2005; Lysaker et al., 2005; Schenkel et al., 2005; Üçok
and Bikmaz, 2007; Lysaker and Larocco, 2008; Meade et al., 2009).
Despite elevated risk of PTSD and the associated impairment
among individuals with SMI, the literature regarding the
implementation of trauma- and PTSD-focused psychotherapy in
this clinical population remains underdeveloped. This gap in data
is due in part to the historical exclusion of patients with current
psychotic symptoms, recent histories of suicidal or unstable
behavior, and/or severe illness burden from participation in
PTSD clinical trials (Spinazzola et al., 2005); as well as concerns
by some clinicians that intense trauma focused interventions
may be ‘over-stimulating’ for individuals with SMI (Braiterman,
2004; Fowler, 2004; Frueh et al., 2006a). Published studies include
a handful of small open trials (Rosenberg et al., 2004; Mueser
et al., 2007; Lu et al., 2009) and one randomized controlled
trial (RCT), each of which used a similar cognitive restructuring
intervention in samples of community mental health center
(CMHC) patients (Mueser et al., 2008). Two additional open
trials examined the efficacy of an exposure-based intervention
for PTSD among individuals with SMI, one in a CMHC and
the other in a VA Medical Center (Frueh et al., 2009; Grubaugh
et al., 2016, respectively). Finally, one small RCT and two larger
RCTs conducted in the Netherlands with community outpatients
reported on the efficacy of two common types of exposure
therapy (de Bont et al., 2013, 2016; van den Berg et al., 2015).
Collectively, results from these trials suggest that specialized
PTSD interventions are effective among patients with SMI
(both civilian and veteran) and result in statistically significant
reductions in PTSD symptoms across treatment (Frueh et al.,
2009; Grubaugh et al., 2016) or between active and control group
conditions (Mueser et al., 2008).
Although preliminary PTSD treatment outcome data for
individuals with SMI are promising, there is significant room
for an increased understanding of how this subset of trauma
survivors respond to targeted PTSD intervention—particularly
individuals with a psychotic spectrum disorder, given diathesis
stress models of psychosis (Grubaugh et al., 2011). As such, the
current manuscript used mixed qualitative/quantitative methods
to better understand how a sample of 14 patients with a
psychotic spectrum disorder (i.e., schizophrenia, schizoaffective,
and psychotic disorder NOS) responded to Prolonged Exposure
(PE) for PTSD (Foa and Rothbaum, 1998) using a range of




The current study was part of a larger open trial of PE for PTSD
among veterans with a psychotic spectrum disorder (Grubaugh
et al., 2016). The active intervention phase (i.e., treatment
phase) consisted of approximately 10–15 weekly individual
sessions of PE, a widely disseminated manualized exposure-based
intervention for trauma and PTSD (Foa and Rothbaum, 1998).
Participants completed an initial (baseline) assessment prior to
the initiation of treatment, an assessment immediately following
the conclusion of treatment, and a final follow-up assessment
6 months after treatment completion. Follow-up assessment data
reported in the current study reflects immediate post-treatment
data due to low frequency of 6-month follow-up data.
Participants
Fourteen (14) veterans with a psychotic spectrum disorder were
enrolled in the current study and included in the current
analysis plan. These veterans were part of a larger clinical trial
for PTSD that included a broader case-mix of SMI diagnoses
(Grubaugh et al., 2016). The 14 veterans in the current study
consist of the subset of patients from the larger trial that
had a diagnosis of a psychotic disorder. Procedures for the
current study were identical to that of the larger trial. All
veterans had a history of psychiatric hospitalization and impaired
psychosocial functioning and generally required assistance with
independent living and symptom/medication management as
documented within individual patient clinical records and by
their disability status. Medication titration was not part of the
study, and veterans remained on their current medications
and dosing pre- to post-intervention. Diagnoses of a psychotic
disorder and PTSD were verified via clinician-administered
semi-structured diagnostic interviews (detailed below). Exclusion
criteria for study consisted of current substance dependence,
current psychiatric hospitalization, or a recent suicide attempt
within 2 months of enrollment in the study.
Assessment Measures
Eligibility for the intervention trial was determined using the
following measures:
The Trauma Assessment for Adults (TAA; Resnick, 1996) was
used to identify an index trauma for treatment at baseline (i.e.,
to confirm PTSD criterion A; American Psychiatric Association
[APA], 2000). The index trauma was limited to one “type” of
traumatic event (i.e., combat or sexual assault) but could include
both discrete and/or chronic types of trauma (i.e., single sexual
assault, child sexual abuse). In cases where there were multiple
events related to the same trauma (i.e., child sexual abuse) a
‘worst’ event was selected if possible and the PTSD assessment
was anchored that that ‘worst’ event.
The Clinician-Administered PTSD Scale (CAPS; Blake et al.,
2005) assessed the frequency and intensity of current PTSD
symptoms using DSM-IV criteria. The CAPS is a well-established
measure for determining PTSD diagnoses and possesses strong
psychometric properties and diagnostic application (Weathers
et al., 2001), and it has been previously utilized to reliably
diagnose PTSD in SMI populations (Grubaugh et al., 2011).
PTSD diagnoses were confirmed during the baseline assessment
with the CAPS using the F1/I2 scoring algorithm (Weathers
et al., 1999). Likewise, the CAPS was used as the primary clinical
outcome at follow-up.
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The Mini-International Neuropsychiatric Interview for
DSM-IV (MINI for DSM-IV; Sheehan et al., 1998) is a clinician-
administered, semi-structured diagnostic interview that
was used to confirm the presence of a psychotic disorder
at baseline. Comorbid psychiatric conditions were also
identified using the MINI. Veterans who endorsed current
alcohol/substance dependence during the MINI were excluded
from the intervention trial. The MINI is a well regarded
diagnostic tool that demonstrates sufficient diagnostic sensitivity
and specificity in comparison to more extensive clinician-
administered diagnostic interviews (e.g., SCID; Sheehan et al.,
1998).
The PTSD Checklist (PCL; Weathers et al., 1993) is a brief self-
report measure of PTSD symptoms based on DSM-IV diagnostic
criteria. In the current study, the PCL was administered at each
assessment time point and during each treatment session. The
PCL has 17 items, and individual item scores are summed to yield
a total score ranging from 17 to 85. The PCL demonstrates a high
correlation with the CAPS (r = 0.93) and sufficient diagnostic
efficiency of PTSD (>0.70) within multiple trauma populations
(Weathers et al., 1993; Blanchard et al., 1996).
A Reactions to PTSD Research Survey, developed by the
study team in previous research, was used at the post-assessment
to obtain quantitative ratings of veterans’ reactions to the
intervention. The survey used a 10-point Likert scale that
assessed six domains: (1) distress, (2) difficulty, and (3) confusion
associated with study research procedures; (4) participation
satisfaction; (5) perceived value of the research experience; and
(6) willingness to participate in comparable research in the future.
A modified Treatment Expectancy (Borkovec and Nau, 1972)
form was administered after the third treatment session to assess
the subjective treatment outcome expectancies and perceptions
of treatment credibility of study participants. Four questions on
this measure were selected for use in the current study: (1) patient
perception of the treatment rationale; (2) patient confidence
in the treatment addressing PTSD; (3) patient willingness to
recommend the treatment to others; and (4) patient expectation
for treatment success.
Procedure
Participants were recruited through direct referrals from VA
service providers in a specialized mental health clinic, the PTSD
Clinical Team (PCT), of a Southeastern VAMC. That is, veterans
initially presenting for treatment to this clinic were referred to
study personnel if they had a diagnosis of a psychotic disorder
in their electronic medical records. Veterans who expressed an
interest in receiving treatment through the study were then
contacted by study staff to schedule a baseline assessment and
determine eligibility. At the time of enrollment, veterans had VA
case managers and were on psychotropic medications at the time
of enrollment but were not receiving any other psychotherapy at
the time. The baseline assessment was conducted by the study
team and included a thorough review of the study rationale
and procedures followed by informed consent and a battery of
instruments. Eligibility was determined by a positive diagnosis
of PTSD on the CAPS and a positive diagnosis of a psychotic
disorder on the MINI. The study was conducted with full
approval from the associated institutional review boards and data
collection occurred between January 2008 and December 2012.
Intervention
Prolonged Exposure was administered, consistent with the PE
manual, in 10–15 weekly individual sessions (Foa and Rothbaum,
1998). While PE is implemented in 10 sessions as standardized
by the protocol, up to five additional sessions were allowed if
clinically warranted, given the novelty of the patient population1.
Sessions 1 and 2 included psychoeducation, discussion of
expectations for therapy, and instruction in diaphragmatic
breathing and progressive muscle relaxation. Subsequent sessions
consisted of imaginal exposure of the trauma narrative based
on the identified index event and in vivo exposure exercises
based upon a constructed hierarchy of fear provoking stimuli or
situations. For patients with multiple traumas of the same theme
(i.e., those with multiple combat experiences or child sexual
abuse), exposure exercises focused on the ‘worst’ event first and
then proceeded to other events as warranted based on habituation
to this ‘worst’ event. Treatment sessions lasted approximately




Statistical assumptions for planned data analyses were evaluated
via calculations of demographic and baseline clinical variables
descriptive statistics (i.e., measures of central tendency,
variability, and frequency distributions). Baseline characteristics
for those who completed eight or more sessions of the
intervention were compared to the remainder of the sample
using Chi-square or Fisher’s Exact Test for dichotomous variables
and t-tests for continuous variables. Similar comparisons were
made between those who attended four or more sessions of the
intervention to the remainder of the sample.
Feasibility Analyses
The feasibility analyses used the full sample size of 14 veterans
with a psychotic spectrum disorder enrolled to receive PE
for PTSD. Feasibility outcomes included patients enrolled in
the intervention who did not attend any sessions, those who
completed only one session, those who completed less than
four sessions, those who completed less than eight sessions, and
those who completed 11–15 sessions. Assessment items related
to treatment expectations and study participation reactions were
evaluated with mean/standard deviation calculations.
Clinical Outcome Analyses
Clinician-Administered PTSD Scale PTSD analyses consisted
of participants who completed at least four treatment sessions
(n = 10; i.e., received at least two sessions of imaginal exposure).
Post-scores were missing for one of the ten subjects who
attended at least four sessions, yielding a completer sample
1Veterans were offered additional sessions by their therapist if they reported
significant symptoms on the PTSD Symptom Checklist (PCL) toward the end of
the standard course of treatment (i.e., by session 7 or 8). Only one Veteran in the
current sample was offered and received additional sessions.
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of nine participants for CAPS outcome analyses pre- to post-
intervention. The full sample size (n = 14) was not used because
the assumption of missing at random (MAR) was questionable
for methods such as multiple imputation, and the sample size was
prohibitively small for complex methods for data not missing at
random.
The secondary efficacy outcome measure was the PCL
evaluated prior to participation in therapy (baseline), after
each therapy session during the active intervention phase,
and at post-intervention. 95% confidence intervals and the
paired t-test were used to estimate the magnitude and
test statistical significance of change from baseline to post-
treatment for CAPS total score and PCL. In a second approach
for the PCL, mixed effects modeling (MEM) was used to
estimate the slope of scores across the study time period. The
trajectory for sessions 1–10 was used for these analyses as this
was the standard course of treatment recommended for all
patients by the PE manual. Because of the single arm design,
analyses of symptom improvement (i.e., efficacy) are considered
descriptive and hypothesis generating rather than hypothesis
testing.
Qualitative Data Collection and Analysis
Thematic Interview
All participants completed a clinician administered thematic
interview at the end of treatment (or when patient was
willing, at drop-out) to learn more about their reactions,
perceptions, beliefs, preferences, and suggestions for PE.
A flexible interview approach was used, providing the patient
with topics and subject areas of inquiry but allowing for
additional commentary or queries as indicated. Discussions
lasted about 30 min and were audiotaped for later transcription
and analysis.
Data Management/Analysis
Data was coded using a constructivist grounded theory approach
(e.g., Charmaz, 2006). First, multiple thorough readings of
interview transcriptions by three independent coders was
conducted for content analysis. Each independent coder then
generated an independent list of thematic categories and
subcategories. After the primary coder further developed and
ordered the data, the themes were reviewed, refined, and
finalized by the group. This analytic approach has been used
successfully by the authors with a range of patient and




See Table 1 for demographics and baseline severity data on the
full sample (n = 14) and those included in the completer efficacy
analyses (n = 10). Comparisons were made between veterans
who completed a minimum of eight sessions (i.e., standard
course of therapy; n = 8) relative to the remainder of the
sample (n = 6) by age, service era, baseline CAPS total scores,
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Completers attended four or more sessions and had available CAPS post-data
(n = 9). Non-completers attended fewer than four session (n = 4) or were missing
post-data (n = 1), yielding a total of n = 5 participants.
race/ethnicity, marital status, and index trauma. Race/ethnicity,
marital status, or index trauma were not statistically different
across groups. However, statistically significant group differences
emerged by age, service era, and baseline CAPS total scores.
More specifically, veterans completing less than eight sessions
tended to be younger, M(SD)= 38.67(12.50) versus 52.88(11.08),
t=−2.38, p= 0.04; and 50% of those who received less than eight
sessions were Operation Enduring Freedom/Operation Iraqi
Freedom (OEF/OIF) [χ2(3, n = 14) = 8.90, p = 0.03]. Veterans
completing less than eight sessions also had higher baseline CAPS
total severity scores relative to the remainder of the sample,
M(SD)= 87.17(20.12) versus 67.00(15.75), respectively, t = 2.11,
p= 0.05.
Similar comparisons between veterans completing four or
more sessions (minimum course of therapy; n = 10) relative
to the remainder of the sample (n = 4), yielded more
pronounced differences by CAPS pre-treatment severity scores,
M(SD)= 94.75(7.80) for those completing less than four sessions
versus M(SD) = 68.00(18.04) those completing four or more
sessions, t = 2.81, p = 0.01. Age and service era differences
became non-significant but demonstrated similar trends, and
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employment status, race/ethnicity, marital status, and index
trauma remained non-significant.
Feasibility Data
Of the 14 veterans enrolled with a psychotic spectrum disorder, 9
completed a post-treatment assessment/thematic interview (i.e.,
had complete data). Of the five who did not complete the
assessment immediately following the completion of therapy,
three dropped out of treatment prior to session three and were
not invited for a post-assessment given the recent timing of their
initial assessment; the other two declined follow-up. With regard
to treatment, 2 veterans attended one session of PE, 10 attended
four or more sessions of PE, and 8 attended eight or more sessions
of PE, including one (1) veteran who received fifteen sessions (i.e.,
more than the standard course of treatment)2.
Treatment Expectancy
Treatment expectancy variables collected at the end of session 3
suggested that veterans generally found the intervention to be
logical, M(SD) = 8.14(1.57). Ratings regarding how confident
veterans were in a) the treatment addressing PTSD symptoms
[M(SD) = 5.71(2.56)]; b) likelihood of recommending PE to
others [M(SD)= 6.43(3.21)]; and c) the intervention successfully
decreasing another fear [M(SD) = 6.25(3.01)] were all in the
moderate to high end.
Survey Based Reactions to the Intervention
Reactions to the intervention variables were in the low
to moderate range with regard to how (a) distressing
[M(SD) = 5.33(3.04)]; (b) difficult [M(SD) = 2.67(2.40)];
and (c) confusing veterans found the research procedures and
intervention [M(SD) = 5.22(3.42)]; and in the moderate
to high range with regard to how (a) satisfied they
were with their participation [M(SD) = 8.00(1.50)]; (b)
worthwhile they perceived their research participation to
be [M(SD) = 8.11(1.36)]; and (c) willing they would be to
participate in a similar study in the future [M(SD)= 7.78(2.73)].
Clinical Outcomes
Completer clinical outcome analyses (n = 9) yielded significant
pre- to post-changes in CAPS severity scores, −24.8 (95% CI:
−44.5, −5.0), p = 0.02; as well as significant pre- to post-
changes in PCL scores, −14.1(95% CI: −20.0, −8.1), p = 0.001.
See Figures 1, 2 for trajectories of CAPS and PCL scores from
baseline to post-intervention. With regard to total % change in
CAPS scores pre- to post-intervention, 78% of veterans had at
least a 10% decrease from baseline to post-intervention, and
55.6% (n = 9) had at least a 50% decrease baseline to post-
intervention (i.e., responder proportion). Additional analyses
examining the trajectory of PCL scores across treatment sessions
using MEM provided supportive evidence of a significant decline
2Of the 6 veterans who did not complete the standard course of treatment (i.e., 8
or more sessions), 2 cited transportation problems as their reason for drop-out; 2
did not respond to follow-up attempts, 1 was a treatment responder who no longer
wanted treatment due to symptom amelioration; and 1 stated he was no longer
interested in participating in the study.
in PCL means over the treatment trajectory (Estimated slope
from MEM:−1.3 (SE= 0.3), p= 0.002) (Figure 3).
Of the veterans who attended at least eight treatment sessions,
six of eight experienced remission of PTSD diagnosis at post-
intervention. Additionally, one (1) of the veterans who attended
five sessions no longer met criteria for PTSD at post-intervention,
yielding a total of seven of nine treatment responders among
those who received at least four sessions of the intervention
(National Center for PTSD, 2006).
Two veterans remained symptomatic at post-despite receiving
at least 10 sessions and another veteran remained symptomatic at
post-after completing 8 sessions and dropping out of treatment
prematurely. As noted previously, three veterans dropped out of
treatment prior to session three, one prior to session four, and
another prior to session 6.
Thematic Interviews
Thematic interviews were designed to learn more about veterans’
reactions, beliefs, preferences, and suggestions for PE. Of the nine
thematic interviews available for analysis, six were with veterans
who were considered treatment responders (i.e., no longer had
PTSD at follow-up and/or experienced a statistically significant
decrease in CAPS severity pre- to post-intervention). The other
3 interviews were with veterans who remained symptomatic
post-treatment [2 who completed 10 sessions (i.e., the standard
course of treatment) and 1 who dropped out of treatment after 8
sessions].
With regard to the content of thematic interviews, five higher
order categories were derived based on relative frequency of
occurrence in the thematic interview transcriptions:
Veterans reported long histories of untreated trauma-
related symptoms. Most veterans reported suffering from PTSD
for several years, with some index traumas occurring more than
20 years prior to the baseline assessment. Despite this, none of
the veterans interviewed reported having received specialized
therapy for PTSD in the past. One veteran stated, “Nobody said
anything about PTSD even though I had this problem for a long
time, and this is what I kept telling them over and over again,
you know.” Yet another veteran noted, “Well I’m 52 now and
this happened when I was 14 years old and I have never spoken
to anyone about it. Till, you know, I did it here. . .When people
used to ask me about it, I would just brush it off, or say I don’t
want to talk about it, or that’s the past, I don’t really want to visit
it.”
Veterans reported being apprehensive at the start of
treatment regarding their ability to deal with the difficult
emotions and memories that they believed the intervention
would solicit. Veterans, similar to other patient populations
enrolled in PE or trauma intensive services, expressed concerns
about their ability to manage imaginal exposure sessions (i.e.,
talking about their trauma in detail) and about the potential
adverse consequences of bringing up upsetting/distressing
memories. Among those who responded to the intervention,
these fears seemed to decrease as treatment progressed. For
example, one treatment responder stated, “Like at first when we
started, like it was really difficult to tell the story. It made me
upset and made me feel as if I was reliving it as I told it. . .
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FIGURE 1 | Trajectories of CAPS total scores from baseline to immediate post-treatment.
FIGURE 2 | Trajectories of PCL scores from baseline to immediate post-treatment.
and as I got to the end, it was almost boring.” Other treatment
responders stated, “I was a little scared of what it would stir
up but I’m happy with the outcome”; and “It’s still upsetting,
but not like just the whole thing before, it would upset me for
like a long time too—you know, for like a couple of hours I
would just be in a bad mood, and now not so much, so I think
it’s really helped.” For the three veterans who did not respond
to treatment or dropped out prematurely this distress/anxiety
seemed to persist.
Veterans tended to view the treatment and/or treatment
team as credible, and this seemed to encourage veterans to
“stick with the treatment” despite their anxiety. One veteran
Frontiers in Psychology | www.frontiersin.org 6 June 2017 | Volume 8 | Article 977
fpsyg-08-00977 June 28, 2017 Time: 16:40 # 7
Grubaugh et al. Prolonged Exposure for PTSD
FIGURE 3 | PTSD checklist total score at baseline, immediate post, and after each session.
[treatment responder] who reported having a lot of anxiety in
the beginning of treatment was asked by the interviewer how
he managed his anxiety, and he stated, “I guess I took a chance
and trusted that you guys would help me through it, and that my
wife would help me through it.” Another treatment responder who
was not initially confident noted, “Well at first I thought it’s not
going to work. Just the way I can’t really open up that much. But it
happened though, something happened and you now, once I got to
talking about it and the way I felt afterward, I felt you know real
shaky and stuff like that but funny thing about it is, I feel good.”
Even the three veterans who did not respond to treatment or
dropped out prematurely viewed the treatment as logical. One
of these veterans stated, “When I first started right, I felt that the
treatment was helping and um I was confident –you know—that I
could be helped. Then, as I got deeper into the sessions, I felt that it
was bringing things out of me that I didn’t want to deal with. But as
far as the treatment, it makes sense. The things that Ms. ∗∗∗∗ was
showing me made sense and I feel that I, my part of the bargain,
you know, I failed because I couldn’t handle it.”
Both treatment responders and non-responders reported a
number of benefits of the intervention. Treatment responders
tended to report an improved ability to manage thoughts related
to the trauma and a greater awareness of how their symptoms
were affecting their daily lives. For example, one veteran stated
“It’s okay for me to deal with it now. I realize you know, that it was
over there, you know, and it’s not going to happen over here”; and
another reported “I could think about what happened and not fall
to pieces anymore and not have to go to the hospital and stick my
head in the sand.”
Treatment non-responders tended to report being better able
to talk about the trauma, a decrease in overall severity of distress
[albeit not an elimination of symptoms], and/or having a better
ability to manage their trauma-related distress. For example, one
veteran stated “I can talk about it now and before I didn’t want
to”; and yet another veteran who was a treatment non-responder
stated, “On command now I can say stop and gather my thoughts
when I’m getting to that point. That helps me you know. The things
that I learned I got pretty well embedded in me. So I can always
say, well okay, I don’t have to be in control.”
Although there was little evidence of relapse or
exacerbations in symptoms, some difficulties with the
intervention were noted. Generally speaking, veterans did not
report experiencing a worsening of symptoms –either with
regard to PTSD or their primary SMI symptoms. Consistent with
this, when asked directly whether his symptoms were worse,
better, or the same since his enrollment in the study, one veteran
[a treatment non-responder] stated, “They’re about the same.
Most days, as long as I don’t think about it, I can live a normal
life.”
Difficulties and/or challenges associated with the intervention
generally consisted of initial fears regarding the intensity of the
intervention (as noted above) and difficulty managing negative
affect outside of sessions. With regard to the latter, one veteran
[a treatment non-responder] stated, “It’s like I said, once I’m here,
I can be in here, and talk with her (therapist). She will speak to
me and I can go home that day and feel less symptoms, but then
another day I’m not seeing her, or something, and I’m back in this
rut or whatever, and start not feeling so good, and start thinking
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about these things, and start hearing things, and seeing things I
guess. But I hear them a lot of times too. . .. It just didn’t stick, you
know. Just not how I would like it to be.”
DISCUSSION
Results of the current study suggest that an exposure-based
intervention for PTSD is generally well tolerated and can
be therapeutically beneficial among patients with a psychotic
spectrum disorder. Quantitative data indicate that seven out of
nine veterans experienced remission of PTSD diagnosis at follow-
up, and the trajectory of PTSD symptoms over the course of
treatment was comparable to general population samples (e.g.,
Bradley et al., 2005; Cloitre, 2009). Additional data suggest that
PE was generally perceived as feasible, logical, and not overly
distressing; and veterans typically held favorable expectations
with regard to treatment. Qualitative data further suggest that
individuals with a psychotic spectrum disorder tend to have
similar reactions to PE as other PTSD clinical populations
(Foa and Rothbaum, 1998). That is, they have concerns about
their ability to manage their distress at the onset of treatment,
but this distress typically decreases as they progress through
treatment and make gains. Additionally, even treatment non-
responders/drop-outs noted some benefits of the intervention,
and no veteran experienced a significant exacerbation in PTSD
symptoms [or other symptoms] as a result of treatment. Despite
misassumptions that trauma-focused therapy may exacerbate
symptoms of SMI, no study-related adverse events occurred
during the course of the intervention trial. Collectively, these data
suggest that individuals with psychotic spectrum disorders do not
respond to targeted PTSD intervention in a dramatically different
manner than individuals without an SMI.
Notwithstanding a number of positive findings with regard to
treatment completers, there were some meaningful differences
between those who failed to complete at least four or eight
sessions of the intervention and the remainder of the sample.
Younger veterans and OEF/OIF veterans were at increased risk
to prematurely drop out of the intervention relative to older
veterans and other service era cohorts. Given the overlap between
age and service era, it is difficult to reach a conclusion regarding
the variable dropout of younger veterans and/or OEF/OIF
veterans. This result should also be interpreted cautiously, as the
non-completer group was small (n = 6). Future studies should
seek to further understand attrition among OEF/OIF veterans
relative to other veteran service era cohorts.
Interestingly, differences in baseline PTSD severity suggested
that veterans with the highest levels of PTSD symptoms
were at greatest risk for premature treatment dropout in the
current analysis. High levels of distress may interfere with
treatment adherence. As such, veterans in ‘high’ distress may
have benefited from a stronger “buy-in” at the onset of
treatment; a shorter time frame between the start of treatment
and receipt of imaginal and in vivo exposure (i.e., the active
elements of PE); motivational interviewing strategies to address
ambivalence about treatment; and/or behavioral activation or
distress tolerance strategies to manage intense emotions and
reduce overall distress. Worth noting again, most veterans
dropped out of treatment prior to the start of imaginal exposure,
as these patients may not have experienced symptom relief
quickly enough to maintain treatment engagement. With regard
to treatment non-responders, qualitative data suggest that these
individuals continued to have fears about their ability to manage
the distress associated with their treatment participation.
Given documented rates of attrition, treatment retention
in trauma-focused and/or exposure-based therapies can still
be significantly improved. Worth noting, however, the rate of
attrition, retention, and treatment completion in the current
study is comparable to prior PTSD treatment outcome studies of
veterans with combat-related PTSD (Bradley et al., 2005; Cloitre,
2009) and SMI or psychotic spectrum disorders (Rosenberg et al.,
2004; Mueser et al., 2007, 2008; Frueh et al., 2009). Additionally,
there are no clear guidelines with regard to standard cutoffs
for a minimum threshold of dosing for PE. If 3, rather than
four sessions, had been used as the cut-off in the current study,
our study results would be comparable to a recent study using
exposure-based interventions among individuals with a psychotic
disorder (van den Berg et al., 2015). With regard to therapeutic
dosing, it appears that most veterans responded to a standard
course of treatment—and those who remained in treatment
tended to get better with some exceptions.
There were some limitations to the current study that require
discussion. First and foremost, the sample is small and study
data are based on a single arm study design, thus limiting firm
conclusions that can be made. Due to the single arm design
of our study, inferential analyses of symptom improvement
(i.e., efficacy) are considered descriptive and can only provide
indications (based on statistically significant p-values) that the
observed improvement in symptom severity is unlikely the result
of chance. That is, the results cannot firmly establish that the
treatment produced the changes because unknown intervening
events cannot be eliminated as causal factors in the observed
improvements in outcomes. Those included in the clinical
outcome analyses were significantly older, had less severe PTSD
symptoms at baseline, and were predominantly Vietnam era
veterans compared to those not included in the analysis sample.
Generalization of efficacy results, therefore, is restricted to the
population of veterans with SMI having characteristics similar
to that of the analysis sample (older veterans with less severe
PTSD symptoms). A final limitation concerns the assessment of
possible variables that influence successful treatment outcomes.
The current study did not include a measure of primary
symptoms of psychosis or other well-established predictors of
treatment success (i.e., therapist adherence to protocol, rapport,
etc.). Addressing such limitations in future studies may provide
information regarding how to maximize treatment response and
possible additional benefits associated with PTSD treatment in
individuals with psychotic spectrum disorders.
The current study addresses important knowledge gaps in the
PTSD treatment outcome literature. First, the current study used
a mixed methods approach to develop a more comprehensive
picture of how individuals with a psychotic spectrum disorder
respond to targeted PTSD intervention. Second, the current
study represents one of a few examinations of PE, a widely
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used, researched, and disseminated exposure-based intervention
for PTSD, in a patient population with a psychotic spectrum
disorder. In this regard the current study findings can be
examined within the context of the broader PTSD treatment
outcome literature. Finally, study participants reflected a diverse
patient population with regards to ethnic/racial identification
[i.e., the majority of the sample (n = 7; 50%) identified as
minority].
Altogether, the current study findings are promising and serve
to mitigate both provider and patient beliefs that individuals
with psychotic spectrum disorders such as schizophrenia cannot
benefit from intense trauma focused treatment. Additional
data along this theme would further disseminate the use
of empirically supported PTSD interventions in this patient
population. Such efforts would undoubtedly facilitate the
establishment of an evidence-based standard of care and
the incorporation of trauma-focused interventions into the
psychosocial rehabilitation conceptualization for this patient
population.
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